Cover image of the article: Evaluation of binding of FITC-prolactin conjugate to prolactin receptor

Image Credit:J Inflamm Dis

Evaluation of binding of FITC-prolactin conjugate to prolactin receptor

Authors

Majid sirati Sabet,*, F Karami Tehrani
*Corresponding Author: Email: sirati_m@yahoo.com

Journal of Inflammatory Diseases:Vol. 10, issue 4; 15-19
Published online:Mar 31, 2007
Article type:Research Article
How to Cite:sirati Sabet M, Karami Tehrani F. Evaluation of binding of FITC-prolactin conjugate to prolactin receptor. J Inflamm Dis. 2024;10(4):e155258. doi:

Abstract

¯Abstract Background: Prolactin is an important mammalian hormone and the associated receptor is recognized in many different cells. Radioligand and histochemical methods are both used for assaying prolactin receptor. Objective: To produce FITC-prolactin conjugate and also to study the ability of conjugate to bind prolactin receptor. Methods: In this experimental study FITC was bound to prolactin in alkaline solution. FITC-prolactin conjugate was separated from free FITC by chromatographic method. Later, the ability of FITC-prolactin conjugate to bind prolactin receptor of peripheral blood mononuclear cells (PBMC) was assessed by flowcytometry. Findings: Fluorescence emission was detected in 2.1% of the cells in absence of FITC-prolactin. Following the addition of FITC-prolactin conjugate to cells for one hour and further washing, the fluorescence emission was detected in 27.8% of cells. For PBMC, these data were 0.02% and 11.8%, respectively. Conclusion: Regarding the data obtained in our study, FITC-prolactin conjugate can bind prolactin receptor. Therefore, this conjugate could be used for assessing prolactin receptor by fluorometric method.

Highlights

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

30
Sep
2000
‌Free prolactin receptor status in breast cancer

‌Free prolactin receptor status in breast cancer

M Sirati Sabet,
F Karami Tehrani,
M Taghikhani,
M Atri

Sirati Sabet M, Karami Tehrani F, Taghikhani M, Atri M. ‌Free prolactin receptor status in breast cancer. J Inflamm Dis. 2024;4(2):e154711. doi:

9
Mar
2019
Is Morning Prolactin Level Sufficient for Diagnosis of Mild Hyperprolactinemia?

Is Morning Prolactin Level Sufficient for Diagnosis of Mild Hyperprolactinemia?

Hamid Reza Ghasemi Basir,
Zahra Razavi,
Mohammad Chehreghani,
Manoochehr Karami,
Arash Dehghan

Ghasemi Basir HR, Razavi Z, Chehreghani M, Karami M, Dehghan A. Is Morning Prolactin Level Sufficient for Diagnosis of Mild Hyperprolactinemia?. J Kermanshah Univ Med Sci. 2019;23(1):e86003. doi: https://doi.org/10.5812/jkums.86003

31
Jan
2012
140 Cases of Macroprolactinemia: Selected Clinical and Technical Laboratory Aspects

140 Cases of Macroprolactinemia: Selected Clinical and Technical Laboratory Aspects

Wojciech Jeske,
Piotr Glinicki,
Renata Kapuscinska,
Wojciech Zgliczynski

Jeske W, Glinicki P, Kapuscinska R, Zgliczynski W. 140 Cases of Macroprolactinemia: Selected Clinical and Technical Laboratory Aspects. Int J Endocrinol Metab. 2012;10(1):. doi: https://doi.org/10.5812/ijem.3600

31
Jul
2011
Regulatory Effects of Dopamine, Oxytocin, and Thyrotropin- Releasing Hormone on the Release of Prolactin Variants From the Adenohypophysis of Lactating Rats

Regulatory Effects of Dopamine, Oxytocin, and Thyrotropin- Releasing Hormone on the Release of Prolactin Variants From the Adenohypophysis of Lactating Rats

Nilda Navarro,
Alejandra Castilla,
Flavio Mena

Navarro N, Castilla A, Mena F. Regulatory Effects of Dopamine, Oxytocin, and Thyrotropin- Releasing Hormone on the Release of Prolactin Variants From the Adenohypophysis of Lactating Rats. Int J Endocrinol Metab. 2011;9(3):. doi: https://doi.org/10.5812/Kowsar.1726913X.3179

30
Apr
2013
Production and Quality Control of [67Ga]-DOTA-trastuzumab for Radioimmunoscintigraphy

Production and Quality Control of [67Ga]-DOTA-trastuzumab for Radioimmunoscintigraphy

Behrooz Alirezapour,
Amir R. Jalilian,
Fatemeh Bolourinovin,
Sedigheh Moradkhani

Alirezapour B, R. Jalilian A, Bolourinovin F, Moradkhani S. Production and Quality Control of [67Ga]-DOTA-trastuzumab for Radioimmunoscintigraphy. Iran J Pharm Res. 2013;12(2):e125694. doi: https://doi.org/10.22037/ijpr.2013.1314

More by these authors

Majid sirati SabetPubMedScholar
F Karami TehraniPubMedScholar
Share
Cited by
Metrics